Canaccord Genuity Group Inc. (CCORF)
| Market Cap | 1.07B +44.8% |
| Revenue (ttm) | 1.56B +34.2% |
| Net Income | -73.81M |
| EPS | -0.73 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | 0.27 (2.61%) |
| Ex-Dividend Date | Aug 28, 2026 |
| Volume | 1,700 |
| Open | 10.27 |
| Previous Close | 10.22 |
| Day's Range | 10.22 - 10.27 |
| 52-Week Range | 6.40 - 11.00 |
| Beta | 1.69 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 7, 2026 |
About Canaccord Genuity Group
Canaccord Genuity Group Inc. operates as a full-service investment dealer in Canada, the United States, the United Kingdom, Europe, Crown Dependencies, and Australia. It operates through two segments: Canaccord Genuity Capital Markets and Canaccord Genuity Wealth Management. The Canaccord Genuity Capital Markets segment offers investment banking, advisory, research, and trading services for corporate, institutional, and government clients. Its Canaccord Genuity Wealth Management segment provides brokerage services and investment advice to retai... [Read more]
Financial Performance
In fiscal year 2026, Canaccord Genuity Group's revenue was 2.09 billion, an increase of 27.75% compared to the previous year's 1.64 billion. Losses were -144.28 million, 399.1% more than in 2025.
Financial numbers in CAD Financial StatementsNews
PharmAla Receives U.S. Patent, Retains APA-01 Rights And Engages Canaccord Genuity
(RTTNews) - PharmAla Biotech Holdings Inc. (MDXXF), announced a U.S. patent grant covering novel enantioselective processes for preparing the individual (R)- and (S)-enantiomers of MDMA and MBDB, stre...
INCY Initiates Coverage On Canaccord Genuity -- Rating Set to Buy
INCY Initiates Coverage On Canaccord Genuity -- Rating Set to Buy
StrikePoint Announces Agreement to Purchase the Northumberland Project, a Gold Deposit in Nevada’s Walker Lane, from Newmont Corporation
Initial Mineral Resource Estimate: Ind. 2.86 Moz AuEq* and Inf. 1.57 Moz AuEq*Bought Deal Financing of C$140 Million Led by Canaccord Genuity**Not for distribution in the United States of America or t...
Canaccord Genuity Group Q1 Earnings Call Highlights
Canaccord Genuity Group TSE: CF reported stronger fiscal 2027 first-quarter results as growth in wealth management and capital markets lifted revenue and profitability, supported by favorable equity m...
Canaccord Genuity Shareholders Back Board as Revenue Tops CAD 2 Billion
Canaccord Genuity Group TSE: CF shareholders approved all matters presented at the company's fiscal 2026 annual general meeting, including the election of six directors, the appointment of Ernst & You...
Canaccord Genuity Group Transcript: AGM 2026
The meeting covered director elections, auditor appointment, and executive compensation, with all motions passed. Fiscal 2026 saw strong revenue and profit growth, driven by wealth management and capital markets, alongside strategic investments and enhanced compliance. No shareholder questions were raised.
Canaccord Genuity Group Earnings Call Transcript: Q1 2027
Firm-wide revenue grew 29% year-over-year, driven by strong wealth management and capital markets performance, with adjusted net income up 120%. Record client assets and improved margins were achieved across all regions, while disciplined expense management and strategic investments supported profitability.
Canaccord Genuity Group Registration statement: Q1 2027
Canaccord Genuity Group filed a registration statement on August 7, 2026, providing details about a securities offering with the SEC.
Canaccord Genuity Group Registration statement: Q1 2027
Canaccord Genuity Group filed a registration statement on August 7, 2026, providing details about a securities offering with the SEC.
Canaccord Genuity Group Earnings release: Q1 2027
Canaccord Genuity Group released its Q1 2027 earnings on August 7, 2026, summarizing the period's financial results.
Canaccord Genuity Group Slides: Q1 2027
Canaccord Genuity Group has posted slides in relation to its Q1 2027 quarterly earnings report, which was published on August 7, 2026.
Pharming Group to participate in Canaccord Genuity 46th Annual Growth Conference
Leiden, the Netherlands, August 4, 2026: Pharming Group N.V. (Euronext Amsterdam: PHARM/Nasdaq: PHAR), today announced its participation in the Canaccord Genuity 46th Annual Growth Conference in Bost...
General Fusion to Participate in Canaccord Genuity Growth Conference
VANCOUVER, British Columbia, July 30, 2026 (GLOBE NEWSWIRE) -- General Fusion Group Ltd. (“General Fusion” or the “Company”) (NASDAQ: GFUZ), a leader in the global race to commercialize fusion energy,...
QuantumCore to Present at Canaccord Genuity's 46th Annual Growth Conference
Waterloo, Ontario--(Newsfile Corp. - July 29, 2026) - QuantumCore Ltd. (CSE: QNCR) (OTCQB: QNCRF) (FSE: K1Y) ("QuantumCore" or the "Company"), a developer of advanced quantum computing infrastructure ...
JAZZ Initiates Coverage On Canaccord Genuity -- Price Target Announces $290
JAZZ Initiates Coverage On Canaccord Genuity -- Price Target Announces $290
ETON Initiates Coverage On Canaccord Genuity -- Price Target Announced at $60
ETON Initiates Coverage On Canaccord Genuity -- Price Target Announced at $60
Canaccord Genuity Group Q4 Earnings Call Highlights
Canaccord Genuity Group TSE: CF reported a record fiscal 2026 revenue total and sharply higher adjusted profitability, as stronger capital markets activity and continued growth in wealth management he...
Canaccord Genuity Group Earnings Call Transcript: Q4 2026
Record revenue and profitability were achieved, driven by strong capital markets and wealth management growth, especially in Canada and Australia. Strategic acquisitions and disciplined expense management supported margin expansion, while the outlook remains positive but cautious due to market volatility.
Canaccord Genuity Group Earnings release: Q4 2026
Canaccord Genuity Group released its Q4 2026 earnings on June 4, 2026, summarizing the period's financial results.
Canaccord Genuity Group Slides: Q4 2026
Canaccord Genuity Group has posted slides in relation to its Q4 2026 quarterly earnings report, which was published on June 4, 2026.
Canaccord Genuity Group Annual report: Q4 2026
Canaccord Genuity Group has published its Q4 2026 annual report on June 4, 2026.
Canaccord Genuity Group Registration statement: Q4 2026
Canaccord Genuity Group filed a registration statement on June 4, 2026, providing details about a securities offering with the SEC.
Canaccord Genuity Group Registration statement: Q4 2026
Canaccord Genuity Group filed a registration statement on June 4, 2026, providing details about a securities offering with the SEC.
Canaccord Genuity Group Slides: Investor presentation
Canaccord Genuity Group has posted slides in relation to its latest quarterly earnings report, which was published on June 3, 2026.
QuantumCore to Present at Canaccord Genuity Virtual Quantum Symposium
Toronto, Ontario--(Newsfile Corp. - May 4, 2026) - QuantumCore Ltd. (CSE: QNCR) ("QuantumCore" or the "Company"), a developer of advanced quantum infrastructure technologies, today announced its parti...